Health Condition 1: K011- Impacted teeth
Conditions
Interventions
Intervention1: Lornoxicam: Lornoxicam Extended-Release formulation 16 mg administered orally, once daily for 3 days.
Control Intervention1: Diclofenac: Prolonged-Release formulation 100 mg administere
Sponsors
Terna Dental College
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients who are willing to participate in the study 2.Patients requiring surgical extraction of bilateral impacted mandibular 3rd molar of similar difficulty (easy or moderate difficulty as per Pederson’s difficulty index) 3.Healthy patients belonging to ASA Class I or II will be included 4.Patients who are not on any pain management therapy or those who have not consumed any NSAID in the last seven days.
Exclusion criteria
Exclusion criteria: 1.Patients not willing to participate in the study 2.H/o Hypersensitivity reactions to Lornoxicam, Diclofenac or any other NSAID 3.Pregnant and lactating patients 4.Patients suffering from Bronchial Asthma or COPD or bleeding diathesis. 5.Patients with H/o gastritis, gastric/ duodenal ulcers, or any other inflammatory gastrointestinal disease 6.Pederson difficulty index score 7-10 (Difficult) 7.Patients having local signs of infection around the impacted tooth to be removed such as periapical abscess/granuloma, pericoronal abscess, fascial space infection etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain evaluation using modified visual analogue scale (0-10)Timepoint: 4 hour, 8 hour, 12 hour, 24 hour, 48 hour, 72 hour | — |
Secondary
| Measure | Time frame |
|---|---|
| Swelling evaluation described by Gabka and Matsumara scaleTimepoint: Postoperative Day 1 and Postoperative Day 3 | — |
Countries
India
Contacts
Public ContactDr Charudatta Naik
Department of Oral and Maxillofacial Surgery
Outcome results
None listed